Semih Eren

Semih Eren

Auto-generated profile, based on publicly available information

Semih Eren

Department of Cardiology, Dr. Siyami Ersek Training and Research Hospital, Istanbul, Türkiye

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Korean Circulation Journal
Verified
Journal Article
Open access
PDF file
LPLevent Pay
Levent Pay
AYAhmet Çağdaş Yumurtaş
Ahmet Çağdaş Yumurtaş
OTOzan Tezen
Ozan Tezen
TÇTuğba Çetin
Tuğba Çetin
SESemih Eren
Semih Eren
ATAhmet İlker Tekkeşin
Ahmet İlker Tekkeşin
Korean Circulation Journal 대한심장학회지 순환기 Pay L, et al. Korean Circ J. 2023 Jun;53:e49. https://doi.org/10.4070/kcj.2022.0353

17 April 2024 in Biomarkers in Medicine
Verified
Journal Article
Closed access
LPLevent Pay
Levent Pay
AYAhmet Çağdaş Yumurtaş
Ahmet Çağdaş Yumurtaş
OTOzan Tezen
Ozan Tezen
TÇTuğba Çetin
Tuğba Çetin
SESemih Eren
Semih Eren
MHMert İlker Hayıroğlu
Mert İlker Hayıroğlu
Aim: There is a lack of data about the association between admission serum albumin levels and long-term mortality in heart failure (HF) patients with cardiac resynchronization therapy defibrillators (CRT-D). We aim to investigate this connection in HF patients with CRT-D. Methods: The study population consisted of 477 HF patients with CRT-D. The cohort was divided into three groups according to albumin values, and the relationship between these groups and long-term mortality were evaluated. Results: Long-term all-cause mortality (HR: 3.32, 95% CI: 2.12-6.84), appropriate (HR: 4.44, 95% CI: 2.44-8.06) and inappropriate (HR: 2.95, 95% CI: 1.88-6.02) shocks were higher in the low albumin group. Conclusion: Low albumin levels are associated with the long-term mortality and appropriate shock treatment in HF patients with CRT-D.

31 January 2022 in Indian Heart Journal
Verified
Journal Article
Open access
GÇGöksel Çinier
Göksel Çinier
MHMert İlker Hayıroğlu
Mert İlker Hayıroğlu
TCTufan Cinar
Tufan Cinar
LPLevent Pay
Levent Pay
AYAhmet Çağdaş Yumurtaş
Ahmet Çağdaş Yumurtaş
KGKadir Gürkan
Kadir Gürkan
Implantable cardioverter defibrillators (ICD) are recommended in heart failure with reduced ejection fraction (HFrEF) patients to reduce arrhythmic deaths. This study aimed to identify risk factors associated with mortality within one-year following the ICD. The data from our hospital's electronic database system was extracted for patients who were implanted ICD secondary to HFrEF between 2009 and 2019. Overall, 1107 patients were included in the present analysis. Mortality rate at one-year following the device implantation was 4.7%. In multivariate analysis; age, atrial fibrillation, New York Heart Association classification >2, blood urea nitrogen, pro-brain natriuretic peptide and albumin independently predicted one year mortality.

20 February 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MKMehmet Karaca
Mehmet Karaca
MKMuhsin Kalyoncuoğlu
Muhsin Kalyoncuoğlu
AZAhmet Zengin
Ahmet Zengin
SESemih Eren
Semih Eren
KKKivanc Keskin
Kivanc Keskin
AÇAli Nazmi Çalık
Ali Nazmi Çalık
Objectives: Our aim was to investigate whether admission advanced lung cancer inflammation index (ALI) values have a prognostic role on one-year major adverse cardiovascular and cerebrovascular events (MACCEs) in non-ST elevation myocardial infarction (NSTEMI) patients undergoing percutaneous coronary intervention (PCI). Methods: Our study consisted of 1173 consecutive patients aged 61.9 ± 12.5 years. The study population was divided into two groups according to the occurrence of MACCEs. BMI (body mass index), serum albumin levels and NLR (neutrophil to lymphocyte ratio) of patients were collected from hospital records, and ALI was calculated based on the following formula: BMI × serum albumin/NLR. We also calculated neutrophil to lymphocyte ratio (NLR), C-reactive protein/albumin ratio (CAR) and uric acid to albumin ratio (UAR) and investigated the association of these inflammation-based biomarkers with one-year MACCEs. Results: During the 12-month follow-up period, 158 (13.5%) patients had MACCEs, 55 (4.7%) of whom had all-cause mortality, 96 (8.2%) had nonfatal MI and 7 (0.6%) had nonfatal stroke. Patients with MACCEs had significantly lower ALI (p < 0.001), and also ALI (area under the curve [AUC] = 0.658, p < 0.001) had better discriminatory power and predictive accuracy in determining one-year MACCEs compared to albumin (AUC = 0.594, p < 0.001), NLR (AUC = 0.631, p < 0.001), CAR (AUC = 0.595, p < 0.001) and UAR (AUC = 0.577, p = 0.001) in the ROC analysis. Individuals with an ALI value lower than 43.9 were at greater risk of developing MACCEs (p < 0.001) due to the Delong test. Conclusions: Determining the level of ALI may have the potential to improve risk prognostication in NSTEMI patients undergoing revascularization therapy.

1 January 2023 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
LPLevent Pay
Levent Pay
AYAhmet Çağdaş Yumurtaş
Ahmet Çağdaş Yumurtaş
OTOzan Tezen
Ozan Tezen
TÇTuğba Çetin
Tuğba Çetin
KKKivanc Keskin
Kivanc Keskin
ATAhmet İlker Tekkeşin
Ahmet İlker Tekkeşin
Heart failure patients with reduced ejection fraction are at high risk for ventricular arrhythmias and sudden cardiac death. Ivabradine, a specific inhibitor of the If current in the sinoatrial node, provides heart rate reduction in sinus rhythm and angina control in chronic coronary syndromes.

16 June 2026 in Angiology
Verified
Journal Article
Closed access
SESemih Eren
Semih Eren
MGMurat Gokalp
Murat Gokalp
ÖGÖzge Çebi Gökalp
Özge Çebi Gökalp
AGAyça Gümüşdağ
Ayça Gümüşdağ
SVSemanur Vural
Semanur Vural
MKMehmet Baran Karatas
Mehmet Baran Karatas
Pulmonary embolism (PE) remains a major cause of cardiovascular mortality, and early identification of high-risk patients is essential. The uric acid-to-albumin ratio (UAR) has emerged as a marker reflecting systemic inflammation. This study aimed to evaluate the prognostic value of UAR for in-hospital mortality in patients with acute PE. This single-center, retrospective study included 1052 consecutive patients diagnosed with acute PE. Clinical characteristics, laboratory parameters, echocardiographic findings, and pulmonary imaging results were obtained from hospital records. Multivariable logistic regression analyses were performed to identify independent predictors of in-hospital mortality. The discriminative performance of UAR was assessed using receiver operating characteristic (ROC) curve analysis. Overall, 70 patients (6.7%) died during hospitalization. Non-survivors had significantly higher UAR values compared with survivors (2.33 vs 1.57, P < .001). In multivariable analysis, UAR C-Reactive Protein, and Pulmonary artery severity index (PESI) score independently predicted in-hospital mortality. UAR demonstrated acceptable discriminative ability (Area under the curve .728; 95% CI: .649-.807; P < .001), with an optimal cut-off of 2.12. The combined use of UAR and PESI demonstrated a modest improvement in predictive performance. UAR is an independent predictor of in-hospital mortality in patients with acute PE. Its combination with the PESI score may provide incremental value for early risk stratification.